The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pezzutto, A.
Right arrow Articles by Clark, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pezzutto, A.
Right arrow Articles by Clark, E. A.
Right arrowPubmed/NCBI databases
*Substance via MeSH

The Journal of Immunology, Vol 138, Issue 1 98-103, Copyright © 1987 by American Association of Immunologists

ARTICLES

Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140

A Pezzutto, B Dorken, G Moldenhauer and EA Clark

The B cell-specific antigen CD22 is a 130/140-Kd complex and is unique among human B cell antigens, since its surface expression is restricted to a subpopulation of Ig+ B cells. Here the function of the CD22 antigen was evaluated by using the mAb HD6, directed against one of the epitopes on the molecule. The HD6 antibody was constimulatory with anti- Ig in inducing small, dense tonsillar cells to proliferate; however, the antibody by itself was devoid of stimulatory activity. Anti-CD22 antibody also induced more anti-Ig-treated B cells to leave G0 and enter the G1 phase of the cell cycle. It also was constimulatory with low-m.w. BCGF and with an antibody to a 50-Kd polypeptide, Bp50, which mediates a BCGF-like activity. Results of kinetic experiments and analysis of different B cell fractions suggested that anti-CD22 acts during an early phase of B cell activation, probably by amplifying the anti-Ig signal. F(ab')2 fragments of anti-CD22 HD6 were as effective as the whole antibody in inducing augmentation of B cell proliferation, showing that the Fc portion of the molecule was not required for the activity. The results of these experiments, together with the intriguing distribution of the Bp 130/140 antigen in B cell ontogeny, suggest that this molecule plays an important role in the process that leads to B cell activation and proliferation.


This article has been cited by other articles:


Home page
 GlycobiologyHome page
A. Varki and T. Angata
Siglecs--the major subfamily of I-type lectins
Glycobiology, January 1, 2006; 16(1): 1R - 27R.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
B. E. Collins, O. Blixt, N. V. Bovin, C.-P. Danzer, D. Chui, J. D. Marth, L. Nitschke, and J. C. Paulson
Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22
Glycobiology, September 1, 2002; 12(9): 563 - 571.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. L. Otipoby, K. E. Draves, and E. A. Clark
CD22 Regulates B Cell Receptor-mediated Signals via Two Domains That Independently Recruit Grb2 and SHP-1
J. Biol. Chem., November 16, 2001; 276(47): 44315 - 44322.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Golay, L. Zaffaroni, T. Vaccari, M. Lazzari, G.-M. Borleri, S. Bernasconi, F. Tedesco, A. Rambaldi, and M. Introna
Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis
Blood, June 15, 2000; 95(12): 3900 - 3908.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Adachi, C. Wakabayashi, T. Nakayama, H. Yakura, and T. Tsubata
CD72 Negatively Regulates Signaling Through the Antigen Receptor of B Cells
J. Immunol., February 1, 2000; 164(3): 1223 - 1229.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. M. Tuscano, A. Riva, S. N. Toscano, T. F. Tedder, and J. H. Kehrl
CD22 Cross-Linking Generates B-Cell Antigen Receptor-Independent Signals That Activate the JNK/SAPK Signaling Cascade
Blood, August 15, 1999; 94(4): 1382 - 1392.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. G. Tangye, J. Wu, G. Aversa, J. E. de Vries, L. L. Lanier, and J. H. Phillips
Cutting Edge: Negative Regulation of Human T Cell Activation by the Receptor-Type Protein Tyrosine Phosphatase CD148
J. Immunol., October 15, 1998; 161(8): 3803 - 3807.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
K. G.C. Smith, D. M. Tarlinton, G. M. Doody, M. L. Hibbs, and D. T. Fearon
Inhibition of the B Cell by CD22: A Requirement for Lyn
J. Exp. Med., March 2, 1998; 187(5): 807 - 811.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
T. L. O'Keefe, G. T. Williams, S. L. Davies, and M. S. Neuberger
Hyperresponsive B Cells in CD22-Deficient Mice
Science, November 1, 1996; 274(5288): 798 - 801.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
L. D. Powell, R. K. Jain, S. Sabesan, and A. Varki
Characterization of Sialyloligosaccharide Binding by Recombinant Soluble and Native Cell-associated CD22
J. Biol. Chem., March 31, 1995; 270(13): 7523 - 7532.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
R. Schulte, M. Campbell, W. Fischer, and B. Sefton
Tyrosine phosphorylation of CD22 during B cell activation
Science, November 6, 1992; 258(5084): 1001 - 1004.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1987 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1987 by The American Association of Immunologists, Inc. All rights reserved.